Rankings
▼
Calendar
REGN FY 2006 Earnings — Regeneron Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
REGN
Regeneron Pharmaceuticals, Inc.
$78B
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$63M
Gross Profit
$41M
64.2% margin
Operating Income
-$107M
-169.1% margin
Net Income
-$102M
-161.3% margin
EPS (Diluted)
$-1.77
Cash Flow
Operating Cash Flow
$23M
Free Cash Flow
$20M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$585M
Total Liabilities
$368M
Stockholders' Equity
$217M
Cash & Equivalents
$238M
← FY 2007
All Quarters
